A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 60
- Population
- ALL · 18 Years
- Duration
- 2026-09-25 to 2028-01-05
- Intervention
- Repeated intravitreal anti-VEGF injection with eyelid speculum
- Comparator
- Not reported
- Outcomes measured
- Between-eye difference in the change in margin reflex distance-1 (MRD-1) from baseline to month 12 — Baseline and 12 mo…; Between-eye difference in the change in margin reflex distance-2 (MRD-2) from baseline to month 12 — Baseline and 12 mo…; Between-eye difference in the change in levator function from baseline to month 12 — Baseline and 12 months; Longitudinal change in MRD-1, MRD-2 and levator function across visits — Baseline, 1, 3, 6 and 12 months; Incidence of clinically significant blepharoptosis — 12 months; Association between cumulative intravitreal injection number and change in eyelid measurements — 12 months; Change in eyelid measurements by anti-VEGF agent — 12 months
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Vision ageing · 100%Abstract contains controlled term: age-related macular degeneration. Source terminology contains: age-related macular degeneration. Abstract supplies longevity context: age-related. Study type is explicitly identified as OBSERVATIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.